In a recent study published in The Journal of Neuroscience, researchers at the University of Alabama at Birmingham uncovered a potential breakthrough in the treatment of Parkinson’s disease. By focusing on a common side effect of Parkinson’s treatments called dyskinesia, a condition characterized by uncontrollable movements, the team identified a protein as a critical factor in the brain’s “bad motor memory.” By blocking this protein, they were able to halt dyskinesia in animal models, offering hope for longer-lasting and more effective Parkinson’s treatments.